
Astellas Pharma
Collaborative Working Project for Overactive Bladder Management
Pages
2
Time to read
4 mins
Publication
Language
English

Pages
2
Time to read
4 mins
Publication
Language
English
This document is a report detailing the Collaborative Working Project between Astellas Pharma Ltd and South Doc Services (SDS) aimed at transforming the management of patients with Overactive Bladder (OAB). The project seeks to develop a new model of care that enhances service provision by allowing less complex OAB patients to be treated in primary care settings by clinical pharmacists and GPs, thereby reducing the need for referrals to specialist urology services. The report outlines specific aims, including the creation of a patient pathway that integrates care closer to home and the establishment of a step-up/step-down service for appropriate patient management. Key challenges identified in the current service provision include significant variations in diagnosis and treatment, increased wait times for specialist care, and capacity issues in secondary care. The integrated model aims to improve patient outcomes, enhance experiences, and alleviate pressure on secondary care services while aligning with NHS objectives for better primary care integration.